CN212262157U

CN212262157U - Physical intraocular pressure reducing device

Info

Publication number: CN212262157U
Application number: CN202020486910.6U
Authority: CN
Inventors: 曹斌; 邱庆华; 曹稳
Original assignee: Individual
Current assignee: Individual
Priority date: 2020-04-07
Filing date: 2020-04-07
Publication date: 2021-01-01
Anticipated expiration: 2030-04-07

Abstract

The embodiment of the utility model discloses physics intraocular pressure reducing device, concretely relates to intraocular pressure reducing technical field, including insulating casing, insulating casing's top is fixed and is equipped with the conductor ring, and insulating casing's bottom is provided with the conductor contact point, insulating casing's inside is equipped with low voltage battery module to and the weak direct current generation module by low voltage battery module drive, the electric current return circuit positive pole of weak direct current generation module, with conductor contact point electric connection and contact with human orbit position and eyelid through the conductor contact point; weak direct current produces the current loop negative pole of module, with conductor ring electric connection to contact through conductor ring and staff or other positions of human body, the utility model discloses a mode of weak direct current physics intraocular pressure reduction, no side effect, no wound, low cost, simultaneously, the physiochemical effect of electric field can accelerate the onset of medicine equally, can cooperate the treatment of medicine.

Description

Physical intraocular pressure reducing device

Technical Field

The embodiment of the utility model provides an intraocular pressure reducing technical field, concretely relates to physics intraocular pressure reducing device.

Background

Glaucoma is the leading irreversible cause of blindness worldwide, and the cause of blindness is mainly the damage of ocular tissues such as optic nerve by excessive intraocular pressure. Intraocular pressure is caused by the presence of aqueous humor in the eye, and normal intraocular pressure is formed by the balance between the generation and outflow of aqueous humor, and is within the range of about 10 to 21mmHg depending on the individual. Higher than 21mmHg is the increased intraocular pressure, and the intraocular pressure of acute glaucoma patients can be even higher than 60 mmHg. Ocular hypertension is mainly due to the obstruction of aqueous outflow. Ocular hypertension causes irreversible damage to ocular tissues such as the optic nerve, resulting in visual field loss until blindness. Glaucoma is treated by lowering the intraocular pressure to the normal range. The existing intraocular pressure reducing treatment measures comprise two types, namely a medicament and an operation. The medicine can be applied in eye drop and oral administration, and has the functions of reducing the generation of aqueous humor and reducing the outflow resistance of aqueous humor. Likewise, surgical treatment regimens, whether laser or open surgery, are designed to reduce aqueous humor production or increase the rate of aqueous humor outflow. It has been proved that the existing glaucoma treatment measures are not ultimate treatment, and the glaucoma treatment is lifelong because the glaucoma treatment is completely cured without selecting once the treatment is performed by using good drugs and good operations for achieving the target intraocular pressure control. New drugs are constantly emerging and developing, and new surgical schemes and technical means are constantly developing;

the prior art has the following defects: existing ocular hypotensive measures, including drugs and surgery, have different indications and are limited in effectiveness. In addition, all the drugs are accompanied by toxic and side effects of different degrees; all surgeries are permanently traumatized to varying degrees and may have concurrent or late complications; the second common disadvantage is the very high economic burden associated with lifelong treatment, especially when using drugs with good antihypertensive effect and less toxic side effects.

SUMMERY OF THE UTILITY MODEL

Therefore, the embodiment of the utility model provides a physical intraocular pressure reducing device, which is used as a third intraocular pressure reducing treatment measure besides medicine and surgery. The embodiment of the utility model provides a by the power drive of low voltage battery module, produce the module through weak direct current and produce weak direct current, the positive negative pole and the human contact in current return circuit let the human body insert the return circuit as an impedance, constitute a weak direct current return circuit, make weak direct current flow through the people's eye. For the glaucoma with non-organic change type, the electric field physicochemical actions of electrolysis, electrophoresis, electroosmosis and the like of weak direct current change the microenvironment of the aqueous humor, so that the generation of the aqueous humor is inhibited, the outflow easiness of the aqueous humor is improved, and the ocular hypertension can be effectively reduced; the electric field physical and chemical effects can also accelerate the pharmacodynamic action of the medicine and prolong the action time of the medicine, so the intraocular pressure reducing device can also be used as an auxiliary appliance to be matched with the medicine for use together. The power supply adopted by the intraocular pressure reducing device is a low-voltage battery, low voltage and small current, and absolute electric safety is guaranteed. The intraocular pressure reducing device has no toxic or side effect and no wound in use, has extremely low use cost, and ensures that the economic burden of lifelong treatment of patients is extremely light.

In order to achieve the above object, the embodiment of the present invention provides the following technical solutions: a physical intraocular pressure reducing device comprises an insulating shell, wherein a conductor ring or other conductors in a grippable shape are fixedly arranged at the top end of the insulating shell, a conductor contact point is arranged at the bottom end of the insulating shell, a low-voltage battery module and a weak direct current generating module driven by the low-voltage battery module are arranged inside the insulating shell, and the positive electrode of a current loop of the weak direct current generating module is electrically connected with the contact point and is in contact with the eye sockets and eyelid parts of a human body through the contact point; the cathode of the current loop of the weak direct current generating module is electrically connected with the finger ring or other conductors in a shape capable of being held, and is in contact with hands or other parts of human bodies through the finger ring or other conductors in a shape capable of being held.

Furthermore, the structure of the insulating shell is in an oval shape and the like which is suitable for the eye circumference of a human body.

Furthermore, the conductor contact point is made of a conductor material and is electrically connected with the anode of the weak direct current loop.

Furthermore, the number of the contact points is set to be a plurality of, and the contact points can also be set according to actual needs, and the distribution of the contact points is adapted to the shape of the eye circumference and the eyelid of the human body.

Furthermore, the conductor ring arranged at the top end of the insulating shell is made of a conductor material and is electrically connected with the negative electrode of the weak direct current circuit.

The embodiment of the utility model provides a have following advantage:

1. through the electrolysis, electrophoresis and electroosmosis of direct current, the microenvironment of the aqueous humor is changed, and the conditions of inhibiting the formation of the aqueous humor and improving the outflow easiness of the aqueous humor are promoted to occur, so that the intraocular pressure is reduced.

2. The power supply adopted by the embodiment is a low-voltage battery, and has low voltage, small current and good absolute safety.

3. The embodiment is used as a lifelong treatment measure for glaucoma, the cost is extremely low, the one-time purchase cost is only hundreds of yuan, the average use cost is kept not more than several yuan per month (the cost of replacing batteries), and the economic burden of a patient is greatly reduced.

Drawings

In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below. It should be apparent that the drawings in the following description are merely exemplary, and that other embodiments can be derived from the drawings provided by those of ordinary skill in the art without inventive effort.

The structure, ratio, size and the like shown in the present specification are only used for matching with the content disclosed in the specification, so as to be known and read by people familiar with the technology, and are not used for limiting the limit conditions which can be implemented by the present invention, so that the present invention has no technical essential significance, and any structure modification, ratio relationship change or size adjustment should still fall within the scope which can be covered by the technical content disclosed by the present invention without affecting the efficacy and the achievable purpose of the present invention.

Fig. 1 is a schematic view of the overall structure provided by the present invention;

fig. 2 is a schematic diagram of the internal structure provided by the present invention;

FIG. 3 is a schematic block diagram provided by the present invention;

in the figure: 1. an insulating housing; 2. a conductor ring; 3. a conductor contact point; 4. a low-voltage battery module; 5. and a weak direct current generation module.

Detailed Description

The present invention is described in terms of specific embodiments, and other advantages and benefits of the present invention will become apparent to those skilled in the art from the following disclosure. Based on the embodiments in the present invention, all other embodiments obtained by a person skilled in the art without creative work belong to the protection scope of the present invention.

Referring to the attached drawings 1-3 of the specification, the physical intraocular pressure reducing device of the embodiment comprises an insulating shell 1, a finger ring 2 is fixedly arranged at the top end of the insulating shell 1, conductor contact points 3 are uniformly arranged at the bottom end of the insulating shell 1, a low-voltage battery module 4 and a weak direct current generating module 5 connected with the low-voltage battery module 4 through a lead are arranged inside the insulating shell 1, the positive electrode of a weak current loop of the weak direct current generating module 5 is electrically connected with the contact points 3 and is in contact with the eye orbit part of a human body through the contact points 3, and the negative electrode of the weak current loop of the weak direct current generating module 5 is electrically connected with the finger ring 2 and is connected with the hand or other parts of the human body through the finger ring 2.

Further, the structure of the insulating housing 1 is in an elliptical shape or the like adapted to the circumference of the human eye.

Further, the conductor contact point 3 is made of a conductor material and is electrically connected with the positive electrode of the weak direct current loop.

Further, the number of the conductor contact points 3 is set to be a plurality, and the distribution and the shape are adapted to contact the circumference of the eye and the eyelid of the human body

Further, a conductor ring 2 arranged at the top end of the insulating shell 1 is made of a conductor material and is electrically connected with a negative electrode of the weak direct current circuit.

The implementation scenario is specifically as follows: the utility model discloses during the use, whole intraocular pressure reducing device's mid portion, be the insulating casing 1 of built-in circuit part and battery, contact point 3 and the ring 2 on upper portion of its lower part are the conductor, be direct current positive negative pole respectively, insulating casing 1's inside is equipped with low voltage battery module 4 and weak direct current and produces module 5, by low voltage battery module 4's power drive, produce module 5 through weak direct current and produce weak direct current, just constitute a weak direct current return circuit after the positive negative pole and the human body contact of current return circuit, the eye socket or eyelid position of the anodal contact people in return circuit, the negative pole can contact the hand, or other and eye have the health position of certain distance, let the human body insert the return circuit as an impedance, make weak direct current flow through people's eye.

The working principle is as follows:

according to the biophysical principle, direct current acts on a human body, physical and chemical effects such as electrolysis, electrophoresis, electroosmosis and the like can occur, and the pH value in local tissues at two ends of an electrode is directly influenced due to the electrolysis effect, so that the physical and chemical properties such as the protein colloid structure, the permeability of cell membranes and the like can be changed; the migration of human body water under the action of an electric field is caused by electrophoresis and electroosmosis, so that the protein concentration under the anode is increased, the cell membrane permeability is reduced, the material exchange through the cell membrane is slowed down, and the tissue water is reduced; thereby reducing the protein concentration under the cathode, increasing the permeability of the cell membrane and accelerating the exchange of substances through the cell membrane. It is inferred that when a direct current flows through the human eye, the microenvironment of the aqueous humor changes, so that either the production of the aqueous humor is suppressed, the outflow resistance of the aqueous humor is reduced, or both.

Although the invention has been described in detail with respect to the general description and the specific embodiments, it will be apparent to those skilled in the art that modifications and improvements can be made based on the invention. Therefore, such modifications and improvements are intended to be within the scope of the invention as claimed.

Claims

1. A physical intraocular pressure reducing device, comprising an insulating casing (1), characterized in that: the top of insulating casing (1) is fixed and is equipped with conductor ring (2), and the bottom of insulating casing (1) is provided with conductor contact point (3), the inside of insulating casing (1) is equipped with low voltage battery module (4) and produces module (5) by the weak direct current of low voltage battery module (4) drive, the current loop positive pole of weak direct current production module (5), with conductor contact point (3) electric connection and contact with human eye socket and eyelid position through conductor contact point (3), the current loop negative pole of weak direct current production module (5), with conductor ring (2) electric connection to contact with staff or other positions of human body through conductor ring (2).

2. A physical intraocular pressure reducing device according to claim 1, wherein: the structure of the insulating shell (1) is in the shape of an ellipse and the like which is suitable for the eye circumference of a human body.

3. A physical intraocular pressure reducing device according to claim 1, wherein: the conductor contact point (3) is made of a conductor material and is electrically connected with the anode of the weak direct current loop.

4. A physical intraocular pressure reducing device according to claim 1, wherein: the number of the conductor contact points (3) is set to be a plurality, and the distribution and the shape of the conductor contact points are in a shape suitable for contacting the eye circumference and the eyelid of a human body.

5. A physical intraocular pressure reducing device according to claim 1, wherein: the conductor ring (2) arranged at the top end of the insulating shell (1) is made of a conductor material and is electrically connected with the negative electrode of the weak direct current circuit.